Back

Conduction system pacing: comparing technical and clinical outcomes with lumenless versus stylet-driven leads

31 March 2025 (11:30 - 12:15)
Organised by: Logo
Congress Presentation Part of: Conduction system pacing 2 Antibradycardia Pacing EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Francesco Deluca

Santa Maria della Misericordia Hospital, Rovigo (Italy)

6 More presentations in this session

Presentation thumbnail
Conduction system pacing vs biventricular pacing in patients with left bundle branch block and resynchronization therapy indication. CONSYST-CRT trial secondary findings
Doctor M. Pujol-Lopez (Phoenix, US)
Abstract Slides Video
Presentation thumbnail
Long-term mechanical synchrony in left bundle branch area pacing
Doctor A. Estevez Paniagua (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Impact of baseline QRS morphology on right ventricular function during long-term LBBAP in patients with atrioventricular block
Doctor C. Pestrea (Brasov, RO)
Abstract Slides Video
Presentation thumbnail
Conduction system versus biventricular pacing upgrade in patients with pacing-induced cardiomyopathy
Doctor G. Coluccia (Lecce, IT)
Abstract Slides Video
Presentation thumbnail
Different left bundle branch block morphologies and response to CRT: a cohort study
Doctor A. Saplaouras (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Conduction system pacing 2

The Event

Event poster

EHRA 2025

31 March 2025 11:30 CET
You may be interested in
thumbnail
Congress Presentation
From stylet-driven to lumenless leads: what changes in my conduction system pacing technique?
thumbnail
Congress Presentation
Efficacy and safety of lumenless leads compared with stylet-driven leads for left bundle branch area pacing.
thumbnail
Congress Presentation
Left bundle branch area pacing to achieve physiological conduction system activation - the experience of a center

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources